Signals from CD28 induce stable epigenetic modification of the IL-2 promoter

被引:98
作者
Thomas, RM
Gao, L
Wells, AD
机构
[1] Univ Penn, Sch Med, Abramson Res Ctr 916F, Philadelphia, PA 19104 USA
[2] Childrens Hosp Philadelphia, Joseph Stokes Jr Res Inst, Philadelphia, PA 19104 USA
关键词
D O I
10.4049/jimmunol.174.8.4639
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
CD28 costimulation controls multiple aspects of T cell function, including the expression of proinflammatory cytokine genes. One of these genes encodes IL-2, a growth factor that influences T cell proliferation, survival, and differentiation. Antigenic signaling in the absence of CD28 costimulation leads to anergy, a mechanism of tolerance that renders CD4(+) T cells unable to produce IL-2. The molecular mechanisms by which CD28 costimulatory signals induce gene expression are not fully understood. In eukstryotic cells, the expression of many genes is influenced by their physical structure at the level of DNA methylation and local chromatin remodeling. To address whether these epigenetic mechanisms are operative during CD28-dependent gene expression in CD4(+) T cells, we compared cytosine methylation and chromatin structure at the IL-2 locus in fully activated CD4(+) effector T cells and CD4(+) T cells rendered anergic by TCR ligation in the absence of CD28 costimulation. Costimulation through CD28 led to marked, stable histone acetylation and loss of cytosine methylation at the IL-2 promoter/enhancer. This was accompanied by extensive remodeling of the chromatin in this region to a structure highly accessible to DNA binding proteins. Conversely, TCR activation in the absence of CD28 costimulation was not sufficient to promote histone acetylation or cytosine demethylation, and the IL-2 promoter/enhancer in anergic cells remained completely inaccessible. These data suggest that CD28 may function through epigenetic mechanisms to promote CD4(+) T cell responses.
引用
收藏
页码:4639 / 4646
页数:8
相关论文
共 45 条
[1]   Ordered recruitment of chromatin modifying and general transcription factors to the IFN-β promoter [J].
Agalioti, T ;
Lomvardas, S ;
Parekh, B ;
Yie, JM ;
Maniatis, T ;
Thanos, D .
CELL, 2000, 103 (04) :667-678
[2]   Modulation of chromatin structure regulates cytokine gene expression during T cell differentiation [J].
Agarwal, S ;
Rao, A .
IMMUNITY, 1998, 9 (06) :765-775
[3]   An epigenetic view of helper T cell differentiation [J].
Ansel, KM ;
Lee, DU ;
Rao, A .
NATURE IMMUNOLOGY, 2003, 4 (07) :616-623
[4]   The human IL-2 gene promoter can assemble a positioned nucleosome that becomes remodeled upon T cell activation [J].
Attema, JL ;
Reeves, R ;
Murray, V ;
Levichkin, I ;
Temple, MD ;
Tremethick, DJ ;
Shannon, AF .
JOURNAL OF IMMUNOLOGY, 2002, 169 (05) :2466-2476
[5]   TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes [J].
Avni, O ;
Lee, D ;
Macian, F ;
Szabo, SJ ;
Glimcher, LH ;
Rao, A .
NATURE IMMUNOLOGY, 2002, 3 (07) :643-651
[6]   CBP/p300 integrates Raf/Rac-signaling pathways in the transcriptional induction of NF-ATc during T cell activation [J].
Avots, A ;
Buttmann, M ;
Chuvpilo, S ;
Escher, C ;
Smola, U ;
Bannister, AJ ;
Rapp, UR ;
Kouzarides, T ;
Serfling, E .
IMMUNITY, 1999, 10 (05) :515-524
[7]   ATP-dependent nucleosomere modeling [J].
Becker, PB ;
Hörz, W .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :247-273
[8]   Helper T cell differentiation is controlled by the cell cycle [J].
Bird, JJ ;
Brown, DR ;
Mullen, AC ;
Moskowitz, NH ;
Mahowald, MA ;
Sider, JR ;
Gajewski, TF ;
Wang, CR ;
Reiner, SL .
IMMUNITY, 1998, 9 (02) :229-237
[9]   Selective, stable demethylation of the interleukin-2 gene enhances transcription by an active process [J].
Bruniquel, D ;
Schwartz, RH .
NATURE IMMUNOLOGY, 2003, 4 (03) :235-240
[10]   Targeting of p300 to the interleukin-2 promoter via CREB-Rel cross-talk during mitogen and oncogenic molecular signaling in activated T-cells [J].
Butscher, WG ;
Haggerty, CM ;
Chaudhry, S ;
Gardner, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27647-27656